Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Vaxcyte Inc (PCVX)

Vaxcyte Inc (PCVX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
79.74 -2.73 (-3.31%) 02/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 79.74 unch (unch) 16:50 ET
Quote Overview for Fri, Feb 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
79.51
Day High
84.01
Open 83.77
Previous Close 82.47 82.47
Volume 1,252,500 1,252,500
Avg Vol 912,940 912,940
Stochastic %K 6.32% 6.32%
Weighted Alpha -14.90 -14.90
5-Day Change -4.10 (-4.89%) -4.10 (-4.89%)
52-Week Range 58.10 - 121.06 58.10 - 121.06
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,938,554
  • Shares Outstanding, K 124,637
  • Annual Sales, $ 0 K
  • Annual Income, $ -402,270 K
  • EBIT $ -529 M
  • EBITDA $ -554 M
  • 60-Month Beta 0.98
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.69

Options Overview Details

View History
  • Implied Volatility 75.81% ( -2.86%)
  • Historical Volatility 57.27%
  • IV Percentile 86%
  • IV Rank 43.30%
  • IV High 135.29% on 08/06/24
  • IV Low 30.38% on 09/24/24
  • Put/Call Vol Ratio 1.88
  • Today's Volume 2,030
  • Volume Avg (30-Day) 774
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 23,447
  • Open Int (30-Day) 21,526

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.32
  • Number of Estimates 4
  • High Estimate -0.91
  • Low Estimate -2.17
  • Prior Year -1.82
  • Growth Rate Est. (year over year) +27.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.51 +0.29%
on 02/21/25
Period Open: 88.17
93.77 -14.96%
on 01/28/25
-8.43 (-9.56%)
since 01/21/25
3-Month
77.52 +2.86%
on 01/14/25
Period Open: 88.39
94.76 -15.85%
on 12/02/24
-8.65 (-9.79%)
since 11/21/24
52-Week
58.10 +37.25%
on 04/25/24
Period Open: 72.26
121.06 -34.13%
on 09/19/24
+7.48 (+10.35%)
since 02/21/24

Most Recent Stories

More News
Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

PCVX : 79.74 (-3.31%)
Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

PCVX : 79.74 (-3.31%)
MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive

Merck MRK announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of its 21-valent pneumococcal conjugate vaccine (PCV),...

PCVX : 79.74 (-3.31%)
MRK : 89.50 (+2.08%)
PFE : 26.30 (+1.54%)
SNY : 54.46 (+0.61%)
Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference

PCVX : 79.74 (-3.31%)
Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III

Sanofi SNY and its partner SK bioscience announced that they have expanded their agreement to develop, license and commercialize next-generation pneumococcal conjugate vaccines (PCVs) for treating invasive...

PCVX : 79.74 (-3.31%)
MRK : 89.50 (+2.08%)
PFE : 26.30 (+1.54%)
SNY : 54.46 (+0.61%)
New Vaccine Technologies Lead the Charge as Global Immunization Efforts Evolve

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – According to the World Health...

PCVX : 79.74 (-3.31%)
BVAXF : 0.0400 (+2.56%)
BIOV.CN : 0.0550 (+10.00%)
GILD : 109.95 (-0.07%)
GOVX : 1.6700 (+2.45%)
ARCT : 17.77 (+5.02%)
1 Vanguard Index Fund to Buy to Beat the S&P 500 in 2025, According to a Wall Street Bank

Jefferies analysts have set the S&P 500 (SNPINDEX: ^GSPC) with a 2025 target of 6,000. That forecast implies about 1% downside from its current level of 6,050, which ranks among the most bearish outlooks...

PCVX : 79.74 (-3.31%)
JPM : 264.24 (-0.96%)
$SPX : 6,013.13 (-1.71%)
FTAI : 129.31 (-10.09%)
JEF : 65.62 (-1.69%)
SFM : 143.32 (-15.59%)
MLI : 78.39 (-2.72%)
GS : 625.60 (-2.59%)
INSM : 81.06 (-3.05%)
VTWO : 88.08 (-2.92%)
Why Wall Street Rates These 2 Russell 2000 Stocks a “Strong Buy”

These two biotech companies look poised to deliver in the coming year.

PCVX : 79.74 (-3.31%)
$SPX : 6,013.13 (-1.71%)
MRK : 89.50 (+2.08%)
AIT : 245.71 (-6.86%)
PFE : 26.30 (+1.54%)
Insider Sale: CHIEF EXECUTIVE OFFICER of $PCVX (PCVX) Sells 222 Shares

GRANT PICKERING, the CHIEF EXECUTIVE OFFICER of $PCVX ($PCVX), sold 222 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2%...

PCVX : 79.74 (-3.31%)
Insider Sale: SVP of $PCVX (PCVX) Sells 1,435 Shares

Mikhail Eydelman, the SVP of $PCVX ($PCVX), sold 1,435 shares of the company on 12-05-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.3% of their shares....

PCVX : 79.74 (-3.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Vaxcyte Inc.is a biopharmaceutical company develops vaccines for infectious diseases. It offers conjugate, pneumococcal conjugate and complex antigen-based vaccines. Vaxcyte Inc.is based in Foster City, California.

See More

Key Turning Points

3rd Resistance Point 87.16
2nd Resistance Point 85.59
1st Resistance Point 82.66
Last Price 79.74
1st Support Level 78.16
2nd Support Level 76.59
3rd Support Level 73.66

See More

52-Week High 121.06
Fibonacci 61.8% 97.01
Fibonacci 50% 89.58
Fibonacci 38.2% 82.15
Last Price 79.74
52-Week Low 58.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements